Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

164 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
SHARP hydrogel for the treatment of inflammatory bowel disease.
Poláková L, Raus V, Cuchalová L, Poręba R, Hrubý M, Kučka J, Větvička D, Trhlíková O, Sedláková Z. Poláková L, et al. Among authors: hruby m. Int J Pharm. 2022 Feb 5;613:121392. doi: 10.1016/j.ijpharm.2021.121392. Epub 2021 Dec 18. Int J Pharm. 2022. PMID: 34933083
pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects.
Albuquerque LJC, Sincari V, Jäger A, Kucka J, Humajova J, Pankrac J, Paral P, Heizer T, Janouškova O, Davidovich I, Talmon Y, Pouckova P, Štěpánek P, Sefc L, Hruby M, Giacomelli FC, Jäger E. Albuquerque LJC, et al. Among authors: hruby m. J Control Release. 2021 Apr 10;332:529-538. doi: 10.1016/j.jconrel.2021.03.013. Epub 2021 Mar 12. J Control Release. 2021. PMID: 33716094
164 results